2026 Scientific Sessions

Satellite Sessions and Workshops

Breakfast Program: Cath Lab Safety Reimagined—From Policy to Practice (CME)
Breakfast Program: Imaging Reimagined: Transforming Coronary Care With Ultreon™ OCT Software
Breakfast Program: Implementing New Evidence in the Treatment of Valvular Heart Diseases - A Case-Based Discussion on Tricuspid Regurgitation & Aortic Stenosis
Breakfast Program: In the Era of ASD Options: Why I Use the Occlutech ASD Occluder
Breakfast Program: Next-Generation Solutions for Peripheral Vascular Disease: Technology Driving Outcomes
Breakfast Program: Seeing Better and Treating Better With Advanced Coronary Imaging—Live Case Discussion (CME)
Dinner Program: Advancing Left Atrial Appendage Closure: CHAMPION-AF Insights, Post-Implant Drug Regimens and Future Insights
Dinner Program: Bifurcation PCI Reimagined—Data-Driven Decisions in Complex Anatomy (CME)
Welcome and Overview
George D. Dangas, M.D., Ph.D., MSCAI
CT-Guided Bifurcation PCI
Yader B. Sandoval, M.D., FSCAI
DCB in Bifurcation PCI
Vladimír Džavík, M.D., FSCAI
0-0-1 PCI
Tanveer Rab, M.D., MSCAI
The Bifurcation Playbook: Best Practices Shaping Tomorrow’s Guidelines
Yiannis S Chatzizisis, M.D., Ph.D., FSCAI
Dinner Program: Sirolimus-Eluting Balloons in Coronary PCI—Key Insights from Recent Evidence (CME)
Dinner Program: Streamlining Mechanical Thrombectomy in Pulmonary Embolism: From Access to Aspiration
Dinner Program: Treatment and Management of Complex Peripheral Arterial Disease (CME)
Welcoming Remarks
Medical Therapy for Complex PAD
Peter Monteleone, M.D., FSCAI
Aortoiliac Occlusive Disease: Covered or Bare?
Jun Li, M.D., FSCAI
Treatment Femoropopliteal Disease: Bare, Covered, or Drug?
Thuy Pham Ryan, DO
Treatment of Infrapopliteal Disease: Durable, Resorbable, Retrievable?
Sahil A. Parikh, MD, FSCAI
Discussion
Access Considerations in Approaching Complex PAD
Hady Lichaa, MD, FACC, FSCAI
Calcium Modification in PAD
Maya Serhal, MD
Extreme CLTI: Deep Vein Arterialization
Zola M. N'Dandu, M.D.
Acute Limb Ischemia
Jay S. Mathews, MD, MS, FSCAI
Discussion
Is There a Role for Atherectomy in CLTI?
Zola M. N'Dandu, M.D.
Does Drug Choice Matter?: Paclitaxel vs. Limus
Jay Mohan, D.O., FSCAI
BASIL2 vs. BEST-CLI: Endo- or Surgery-First in CLTI
Anish J. Thomas, M.D., FSCAI
Panel Discussion
Lunch Program: Advanced Coronary Intervention: Integrating IVUS and DCB Therapy for Precision and Performance.
Lunch Program: Angio-Derived Physiology—Data, Technology, and Clinical Integration (CME)
Lunch Program: Complete the Reperfusion | The New Era of Myocardial Perfusion in STEMI
Lunch Program: CT-Guided PCI—The Emerging Role of CT for Pre-Procedural Planning (CME)
Lunch Program: Iatrogenic Atrial Septal Defect Closure Therapy and PFO-ASD Case Reviews
Introductory Remarks
Anwar Tandar, M.D., Vamsee Yaganti, MD, Islam Abudayyeh, M.D., FSCAI
Lunch Program: Repair and Replacement: Clinical Decision Making in the Modern Mitral Era
Case Presentations & Discussion: How do you Choose Between Repair and Replacement?
Neil Fam, MD, Vijay S Iyer, M.D., Ph.D., FSCAI, Gennaro Giustino, M.D., Pedro A Villablanca, M.D., FSCAI
Lunch Program: Setting a New Standard in PE Intervention: The AVENTUS System – Combining Efficient Clot Removal with Streamlined Blood Reinfusion
Lunch Program: Strengthening CHD Care: Evolving Product Design and Lifetime Management Considerations
Lunch Program: The End of Watchful Waiting—Long-Term TAVR Evidence and a New Proactive Paradigm (CME)
Lunch Program: The Future of HTN Care Is Now – The Symplicity™ Blood Pressure Procedure
Lunch Program: The Future of TAVR: Contemporary Practice and Evolut™ Platform Data
The Simplified Cusp Overlap Technique: The Why and How
Nicolo Piazza, M.D.
TAVR Durability: Contemporary Data in Low Risk and the Path Forward
Howard C. Herrmann, M.D., MSCAI
Valve Selection and Case Planning
Matthew W. Sherwood, M.D., FSCAI
Panel Discussion
Nicolo Piazza, M.D., Anita W. Asgar, M.D., FSCAI, Matthew W. Sherwood, M.D., FSCAI, Howard C. Herrmann, M.D., MSCAI
Lunch Program: 5 Years of Harmony TPV: Data Driven Evolution of Patient Care
Lunch Program: Clinical Trial Advances and Practice Integration: Translating Evidence into Patient Care
Introductions
Update on OASIS Clinical Trial
Raymond Yau, MD, FSCAI
Protected PCI is Strategy
Sanjog Kalra, M.D.
Panel Discussion
Babar B Basir, DO, FSCAI, Alexandra J. Lansky, M.D., MSCAI, Sanjit S. Jolly, M.D., Norman Mangner
Workshop on Building and Sustaining Your RDN Program (CME)
Workshop on the Treatment of Pulmonary Embolism: PERT Frameworks, Guideline Updates, and Procedural Skills (CME)
Introductory Remarks: Strengthening Your Pulmonary Embolism Response Team
Catalin Toma, M.D.
Developing a Multidisciplinary PERT Program: Lessons Learned and Best Practices
Jun Li, M.D., FSCAI
PERT Centers of Excellence
Kenneth Rosenfield, M.D., MHCDS, MSCAI
Up-to-Date Landscape of PE Data
Jay S. Giri, MD, FSCAI
Panel Discussion
Wissam A Jaber, M.D., FSCAI, Andrew J. Klein, M.D., FSCAI
Acute Pulmonary Embolism Guidelines 2026: Big Picture and Key Takeaways
Jay S. Giri, MD, FSCAI
Clarifying Disease Severity: The Acute PE Clinical Categorization Classification System
Michael N. Young, MD, FSCAI
Discussion
Advanced Therapies in Acute Pulmonary Embolism: Matching Risk, Indication, and Evidence
Jun Li, M.D., FSCAI
On the Horizon: Clinical Trials That May Impact Future Guidelines
Sanjum S Sethi, M.D., MPH, FSCAI
Panel Discussion and Audience Q&A
Preprocedural Patient Evaluation-Risk Assessment
Sripal Bangalore, MD, MHA, FSCAI
Preprocedural Evaluation-Imaging and Device Selection
Vikas Aggarwal, M.B.B.S., FSCAI
Procedural Workflow: How to Avoid Complications
Catalin Toma, M.D.
When to ECMO
Vladimir Lakhter, DO
Panel Discussion
AlphaVac Hands-on Station (Angiodynamics)
Sukhdeep Singh Basra, MD, MPH